155849-49-3

Basic information

• Product Name: 4-(TRIFLUOROMETHYL)PIPERIDINE HYDROCHLORIDE
• Synonyms: 4-(TRIFLUOROMETHYL)PIPERIDINE HYDROCHLORIDE;4-(TRIFLUOROMETHYL)PIPERIDINE HYDROCHLO&;4-(TRIFLUOROMETHYL)PIPERIDINE HCL;4-(Trifluoromethyl)piperidine hydrochloride 97%
• CAS NO: 155849-49-3
• Molecular Formula: C6H11ClF3N
• Molecular Weight: 189.61
• EINECS: -0
• Product Categories: Building Blocks;Heterocyclic Building Blocks;Piperidines
• Mol File: 155849-49-3.mol
• Article Data: 1

Chemical Properties

• Melting Point: 155-159 °C
• Boiling Point: 134℃
• Appearance: /
• Storage Temp.: Room temperature.
• BRN: 1341222
• CAS DataBase Reference: 4-(TRIFLUOROMETHYL)PIPERIDINE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(TRIFLUOROMETHYL)PIPERIDINE HYDROCHLORIDE(155849-49-3)
• EPA Substance Registry System: 4-(TRIFLUOROMETHYL)PIPERIDINE HYDROCHLORIDE(155849-49-3)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26
• WGK Germany: 3
• HazardClass: IRRITANT, IRRITANT-HARMFUL
• Hazardous Substances Data: 155849-49-3(Hazardous Substances Data)

Usage

Uses

4-(Trifluoromethyl)piperidine Hydrochloride is used in the preparation of adenosine receptor antagonists.

InChI:InChI=1/C6H10F3N.ClH/c7-6(8,9)5-1-3-10-4-2-5;/h5,10H,1-4H2;1H

Upstream product

• 3796-24-5 4-trifluoromethylpyridine 

Downstream Products

• 956320-67-5 (3R,5S)-3-[3,5-dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-5-hydroxymethyl-dihydro-furan-2-one 
• 956320-68-6 (R)-3-[3,5-dichloro-4'-(4-trifluoromethyl-piperidine-1-carbonyl)-biphenyl-4-ylmethyl]-5-hydroxy-dihydro-furan-2-one 
• 1191047-90-1 1-{2-[4-(trifluoromethyl)-1-piperidinyl]ethyl}-2-imidazolidinone 
• 860343-95-9 (4-trifluoromethylpiperidin-1-yl)acetic acid methyl ester 
• 862274-38-2 4-(trifluoromethyl)piperidine-1-carbonyl chloride 

Relevant articles and documents

PHENYLACETIC ACID DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE

The present invention relates to the compound represented by formula (I) (wherein R1 and R2 is hydrogen atom, C1-8 alkyl etc.; R3 is C1-8 alkyl which may be substituted with 1 to 3 halogen atom(s), phenyl; R4 is hydrogen atom etc. ; R5 and R6 is hydrogen atom, CI-8 alkyl etc.; X is sulfur atom or oxygen atom etc.; ringA is cyclic group which may have a substituent(s).), or a salt thereof Toxicity of the compound represented by formula (I) is very low, and it is safe enough to use as a pharmaceutical agent and since it has PPAR δ agonistic activity, it is useful as preventive and/or therapeutic agent for glucose lipid metabolic disorder, hypertension, circulatory diseases etc.